BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of USANA Health Sciences, Inc. (“USANA” or the “Company”) (NYSE: USNA) investors concerning the Company and its officers’ possible violations of federal securities laws.
USANA develops, manufactures and sells nutritional and personal care products primarily to reduce the risk of chronic degenerative disease.
On February 7, 2017, USANA disclosed that it will be conducting an internal investigation of its Chinese subsidiary, BabyCare Ltd. (“BabyCare”). Specifically, the Company’s investigation centers upon “compliance with the Foreign Corrupt Practices Act” as well as “BabyCare's expense reimbursement policies.”
On this news, shares of USANA fell over 10% during intraday trading on February 8, 2017.
If you purchased USANA securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to firstname.lastname@example.org, or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.